Clincosm LogoSign in Get a demo

Recurrent Breast Cancer

Showing 76 - 100 of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNS Metastases, Male Breast Cancer, Recurrent Breast Cancer Trial (irinotecan HCl, laboratory biomarker analysis)

Withdrawn
  • Central Nervous System Metastases
  • +3 more
  • irinotecan hydrochloride
  • laboratory biomarker analysis
  • (no location specified)
Oct 7, 2014

Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer Trial in United

Completed
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +3 more
  • Medroxyprogesterone progesterone acetate (MPA)
  • Medroxyprogesterone with Cyclophosphamide + Methotrexate
  • Birmingham, Alabama
  • +6 more
Sep 24, 2014

Lymphedema, Recurrent Breast Cancer, Stage IA Breast Cancer Trial in Los Angeles (radiation, drug, procedure, other)

Terminated
Has Results
  • Lymphedema
  • +4 more
  • technetium Tc 99m sulfur colloid
  • +7 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jul 1, 2014

Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in United States (vorinostat, trastuzumab)

Completed
Has Results
  • Breast Cancer
  • +5 more
  • Birmingham, Alabama
  • +24 more
May 29, 2014

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Boston (biological, drug, other)

Terminated
Has Results
  • HER2-positive Breast Cancer
  • +2 more
  • trastuzumab
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 29, 2014

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Liver Metastases Trial in Duarte

Withdrawn
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +7 more
  • dynamic contrast-enhanced magnetic resonance imaging
  • +2 more
  • Duarte, California
    City of Hope Medical Center
May 28, 2014

Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Washington (sorafenib tosylate, anastrozole)

Completed
Has Results
  • Recurrent Breast Cancer
  • Stage IV Breast Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center at Georgetown University
May 12, 2014

Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Boston (drug, biological, other)

Completed
Has Results
  • Recurrent Breast Cancer
  • Stage IV Breast Cancer
  • pegylated liposomal doxorubicin hydrochloride
  • +3 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
May 7, 2014

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Boston (biological, drug, other)

Completed
Has Results
  • HER2-positive Breast Cancer
  • +3 more
  • trastuzumab
  • +3 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
May 2, 2014

Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer Trial in Boston

Completed
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +3 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Apr 22, 2014

Metastatic Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Rochester (ziv-aflibercept)

Completed
Has Results
  • Metastatic Breast Cancer
  • +2 more
  • ziv-aflibercept
  • Rochester, Minnesota
    North Central Cancer Treatment Group
Apr 2, 2014

Estrogen Receptor-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in New York

Completed
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 2, 2014

Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach, BRCA1 Mutation Carrier Trial in Madison (veliparib, capecitabine,

Terminated
  • Adenocarcinoma of the Pancreas
  • +25 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Apr 1, 2014

Male Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer Trial in Los Angeles (endoscopic surgery, quality-of-life

Terminated
  • Male Breast Cancer
  • +8 more
  • endoscopic surgery
  • quality-of-life assessment
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Feb 5, 2014

Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer Trial (drug, other, genetic, procedure)

Withdrawn
  • Recurrent Breast Cancer
  • +8 more
  • (no location specified)
Feb 5, 2014

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Boston (biological, other, procedure)

Terminated
  • Male Breast Cancer
  • +2 more
  • recombinant vaccinia-MUC1 vaccine
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 10, 2013

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Rochester (sorafenib tosylate, laboratory biomarker

Completed
  • Male Breast Cancer
  • +2 more
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Rochester, Minnesota
    North Central Cancer Treatment Group
Oct 7, 2013

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Columbus (trastuzumab, aldesleukin, laboratory

Completed
  • HER2-positive Breast Cancer
  • +3 more
  • trastuzumab
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 7, 2013

Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Estrogen Receptor-negative Breast Cancer Trial in

Completed
  • Advanced Adult Primary Liver Cancer
  • +87 more
  • Charlottesville, Virginia
    University of Virginia
Sep 27, 2013

Adenocarcinoma of the Gastroesophageal Junction, HER2-positive Breast Cancer, Male Breast Cancer Trial in New York (drug,

Terminated
  • Adenocarcinoma of the Gastroesophageal Junction
  • +11 more
  • Akt inhibitor MK2206
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Sep 27, 2013

Stage IV Breast Cancer, Recurrent Breast Cancer Trial in Houston (antineoplaston A10, antineoplaston AS2-1, alternative product

Withdrawn
  • Stage IV Breast Cancer
  • Recurrent Breast Cancer
  • antineoplaston A10
  • +7 more
  • Houston, Texas
    Burzynski Clinic
Jul 9, 2013

Stage IV Breast Cancer, Recurrent Breast Cancer Trial in Houston (antineoplaston A10, methotrexate, alternative product therapy)

Withdrawn
  • Stage IV Breast Cancer
  • Recurrent Breast Cancer
  • antineoplaston A10
  • +8 more
  • Houston, Texas
    Burzynski Clinic
Jul 9, 2013

CNS Metastases, HER2-positive Breast Cancer, Male Breast Cancer Trial in Boston (drug, other, procedure)

Completed
  • Central Nervous System Metastases
  • +5 more
  • lapatinib ditosylate
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jun 4, 2013

HER2-negative Breast Cancer, HER2-positive Breast Cancer, Recurrent Breast Cancer Trial in Chicago (drug, biological, procedure,

Completed
  • HER2-negative Breast Cancer
  • +4 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jun 3, 2013

Male Breast Cancer, Recurrent Breast Cancer, Recurrent Endometrial Carcinoma Trial in Columbus (trastuzumab, paclitaxel,

Completed
  • Male Breast Cancer
  • +6 more
  • trastuzumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013